CAROLINE D. DORSA - Corporate Board Profile

BIOGEN INC.

Filing Date	Source Excerpt
2014-04-30	Caroline D. Dorsa Age: 55 Director since: 2010 Committee Memberships: Finance and Audit
2015-04-30	Caroline D. Dorsa Age: 56 Committee Memberships: Audit (Chair), Compensation and Management Development, Risk Ms. Dorsa has served as one of our directors since 2010.
2016-04-15	Ms. Dorsa, 56, has served as one of our directors since 2010. Ms. Dorsa served as the Executive Vice President and Chief Financial Officer of Public Service Enterprise Group Incorporated, a diversified energy company, from April 2009 until her retirement in October 2015, and served on its board of directors from 2003 to April 2009. From February 2008 to April 2009, she served as Senior Vice President, Global Human Health, Strategy and Integration at Merck & Co., Inc., a pharmaceutical company. From November 2007 to January 2008, Ms. Dorsa served as Senior Vice President and Chief Financial Officer of Gilead Sciences, Inc., a life sciences company. From February 2007 to November 2007, she served as Senior Vice President and Chief Financial Officer of Avaya, Inc., a telecommunications company. From 1987 to January 2007, Ms. Dorsa held various financial and operational positions at Merck & Co., Inc., including Vice President and Treasurer, Executive Director of U.S. Customer Marketing and Executive Director of U.S. Pricing and Strategic Planning. Ms. Dorsa has significant financial and accounting expertise and a deep knowledge of the pharmaceutical industry. Biogen Committee Memberships: Audit (Chair), Risk. 2015 Director Compensation: $429,508.
2017-04-26	Ms. Dorsa, 57, has served as one of our directors since 2010. Ms. Dorsa served as the Executive Vice President and Chief Financial Officer of Public Service Enterprise Group Incorporated, a diversified energy company, from April 2009 until her retirement in October 2015, and served on its Board of Directors from 2003 to April 2009. Ms. Dorsa has significant financial and accounting expertise and a deep knowledge of the pharmaceutical industry. Biogen Committee Memberships: Audit (Chair), Risk. 2016 Director Compensation: $439,420.
2018-04-27	Ms. Dorsa, 58, has served as one of our directors since 2010. Ms. Dorsa served as the Executive Vice President and Chief Financial Officer of Public Service Enterprise Group Incorporated, a diversified energy company, from April 2009 until her retirement in October 2015, and served on its Board of Directors from February 2003 to April 2009. From February 2008 to April 2009, she served as Senior Vice President, Global Human Health, Strategy and Integration at Merck & Co., Inc., a pharmaceutical company. From November 2007 to January 2008, Ms. Dorsa served as Senior Vice President and Chief Financial Officer of Gilead Sciences, Inc., a life sciences company. From February 2007 to November 2007, she served as Senior Vice President and Chief Financial Officer of Avaya, Inc., a telecommunications company. From 1987 to January 2007, Ms. Dorsa held various financial and operational positions at Merck & Co., Inc., including Vice President and Treasurer, Executive Director of U.S. Customer Marketing and Executive Director of U.S. Pricing and Strategic Planning. Ms. Dorsa also serves as a director of Illumina, Inc. and Intellia Therapeutics, Inc., both of which are biotechnology companies, and as a Trustee of the Goldman Sachs ETF Trust, the Goldman Sachs MLP and Energy Renaissance Fund and the Goldman Sachs MLP Income Opportunities Fund, investment funds within the Goldman Sachs Asset Management fund complex. Ms. Dorsa has significant financial and accounting expertise and a deep knowledge of the pharmaceutical industry. Her strategic perspective on the industry is particularly valuable to our Board of Directors as it oversees our growth initiatives and reviews both internal development projects and external opportunities. Biogen Committee Memberships: Audit (Chair), Risk. 2017 Director Compensation: $416,979.
2019-04-30	Ms. Dorsa served as the Executive Vice President and Chief Financial Officer of Public Service Enterprise Group Incorporated, a diversified energy company, from April 2009 until her retirement in October 2015, and served on its Board of Directors from February 2003 to April 2009. From February 2008 to April 2009 she served as Senior Vice President, Global Human Health, Strategy and Integration at Merck & Co., Inc., a pharmaceutical company. From November 2007 to January 2008 Ms. Dorsa served as Senior Vice President and Chief Financial Officer of Gilead Sciences, Inc., a life sciences company. From February 2007 to November 2007 she served as Senior Vice President and Chief Financial Officer of Avaya, Inc., a telecommunications company. From 1987 to January 2007 Ms. Dorsa held various financial and operational positions at Merck & Co., Inc., including Vice President and Treasurer, Executive Director of U.S. Customer Marketing and Executive Director of U.S. Pricing and Strategic Planning. Ms. Dorsa also serves as a director of Illumina, Inc., a life sciences company, and Intellia Therapeutics, Inc., a biotechnology company, and as a Trustee of the Goldman Sachs ETF Trust, the Goldman Sachs MLP and Energy Renaissance Fund and the Goldman Sachs MLP Income Opportunities Fund, investment funds within the Goldman Sachs Asset Management fund complex.
2020-04-20	Ms. Dorsa served as the Executive Vice President and Chief Financial Officer of Public Service Enterprise Group... Biogen Board Committee: Audit (Chair)... 2019 Director Compensation: Caroline D. Dorsa total $416,643.
2021-04-23	Ms. Dorsa served as the Executive Vice President and Chief Financial Officer of Public Service Enterprise Group... Biogen Board Committee: Audit (Chair)... 2020 Director Compensation: Caroline D. Dorsa total $424,314.
2022-04-29	Ms. Dorsa served as the Executive Vice President and Chief Financial Officer of Public Service Enterprise Group Incorporated... Biogen Board Committee: Audit (Chair)... 2021 Director Compensation: Caroline D. Dorsa Fees Earned or Paid in Cash $155,000, Stock Awards $270,413, Total $425,413.
2023-04-28	Caroline D. Dorsa Director Since: 2010 Independent Chair: after 2023 Annual Meeting Age: 63 Biogen Board Committee: Audit (Chair) 2022 Director Compensation Table: Caroline D. Dorsa Fees Earned or Paid in Cash: $155,000 Stock Awards: $270,246 Total: $425,246
2024-04-26	Caroline D. Dorsa, Independent Chair, fmr. Chief Financial Officer of Public Service Enterprise Group Director since 2010 Age 64 Board Committee Corporate Governance (Chair) ... 2023 Director Compensation Table shows $646,132 total compensation.